Recent advances in the diagnosis of irritable bowel syndrome

References

• El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol 2012;18:5151-63
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Gilja OH, et al. Is irritable bowel syndrome an organic disorder? World J Gastroenterol 2014;20:384-400
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Irritable bowel syndrome: diagnosis, pathogenesis and treatment options. Nova Science Publishers, Inc., New York; 2012
   Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol Hepatol 2014;8:435-43
   PubMed Web of Science ®Google Scholar
• Karantanos T, Markoutsaki T, Gazouli M, et al. Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog 2010;2(1):3
   PubMedGoogle Scholar
• Longstreth GF. Definition and classification of irritable bowel syndrome: current consensus and controversies. Gastroenterol Clin North Am 2005;34:173-87
   PubMed Web of Science ®Google Scholar
• Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770-98
   PubMed Web of Science ®Google Scholar
• Spiller RC. Potential biomarkers. Gastroenterol Clin North Am 2011;40:121-39
   PubMed Web of Science ®Google Scholar
• Abdul-Baki H, El HII, Elzahabi L, et al. A randomized controlled trial of imipramine in patients with irritable bowel syndrome. World J Gastroenterol 2009;15:3636-42
   PubMed Web of Science ®Google Scholar
• Barbara G, Stanghellini V. Biomarkers in IBS: when will they replace symptoms for diagnosis and management? Gut 2009;58:1571-5
   PubMed Web of Science ®Google Scholar
• Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2:653-4
   PubMed Web of Science ®Google Scholar
• Jellema P, van der Windt DA, Schellevis FG, van der Horst HE. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther 2009;30:695-706
   PubMed Web of Science ®Google Scholar
• Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, et al. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient’s lower gastrointestinal tract symptoms? JAMA 2008;300:1793-805
   PubMed Web of Science ®Google Scholar
• Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999;45(Suppl 2):II1-5
   PubMedGoogle Scholar
• Lin OS. Colonoscopy in irritable bowel syndrome: whom are we reassuring? Gastrointest Endosc 2005;62:900-2
   PubMed Web of Science ®Google Scholar
• Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Drossman DA. Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol 2010;105(4):814-20
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Ford AC. Symptom-based diagnostic criteria for irritable bowel syndrome: the more things change, the more they stay the same. Gastroenterol Clin North Am 2011;40:87-103
   PubMed Web of Science ®Google Scholar
• Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109:671-80
   PubMed Web of Science ®Google Scholar
• Garrigues V, Mearin F, Badia X, et al. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study). Aliment Pharmacol Ther 2007;25:323-32
   PubMed Web of Science ®Google Scholar
• Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005;128:580-9
   PubMed Web of Science ®Google Scholar
• Ford AC, Forman D, Bailey AG, et al. Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther 2008;28:1013-20
   PubMed Web of Science ®Google Scholar
• Halder SL, Locke GRIII, Schleck CD, et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007;133:799-807
   PubMed Web of Science ®Google Scholar
• Wong RK, Palsson OS, Turner MJ, et al. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol 2010;105:2228-34
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Palsson OS, Feld AD, et al. Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome. Aliment Pharmacol Ther 2006;24:137-46
   PubMed Web of Science ®Google Scholar
• Hammer J, Eslick GD, Howell SC, et al. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 2004;53:666-72
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Lomholt-Beck B, Gundersen D. The prevalence of celiac disease in patients with irritable bowel syndrome. Mol Med Report 2011;4:403-5
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Halwe J, Lomholt-Beck B, Gundersen D. The prevalence of inflammatory bowel diseases, microscopic colitis, and colorectal cancer in patients with irritable bowel syndrome. Gastroenterology Insights 2011;3:7-10
   Google Scholar
• Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994;89:176-8
   PubMed Web of Science ®Google Scholar
• Camilleri M. Do the Symptom-Based, Rome Criteria of Irritable Bowel Syndrome Lead to Better Diagnosis and Treatment Outcomes? The Con Argument. Clin Gastroenterol Hepatol 2009;8:129
   PubMedGoogle Scholar
• Spiegel BM, Farid M, Esrailian E, et al. Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010;105:848-58
   PubMed Web of Science ®Google Scholar
• Martin R, Barron JJ, Zacker C. Irritable bowel syndrome: toward a cost-effective management approach. Am J Manag Care 2001;7:S268-75
   PubMed Web of Science ®Google Scholar
• Furman DL, Cash BD. The role of diagnostic testing in irritable bowel syndrome. Gastroenterol Clin North Am 2011;40:105-19
   Google Scholar
• May CL, Kaestner KH. Gut endocrine cell development. Mol Cell Endocrinol 2010;323:70-5
   PubMed Web of Science ®Google Scholar
• Gunawardene AR, Corfe BM, Staton CA. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol 2011;92:219-31
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Ostgaard H, Gundersen D, et al. The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). Int J Mol Med 2012;29:723-31
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Seim I, Chopin L, et al. Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci (Elite Ed) 2012;4:2783-800
   PubMedGoogle Scholar
• Tanaka-Shintani M, Watanabe M. Immunohistochemical study of enterochromaffin-like cell in human gastric mucosa. Pathol Int 2007;57:572-83
   PubMed Web of Science ®Google Scholar
• Lonroth H, Hakanson R, Lundell L, Sundler F. Histamine containing endocrine cells in the human stomach. Gut 1990;31:383-8
   PubMed Web of Science ®Google Scholar
• Buffa R, Capella C, Fontana P, et al. Types of endocrine cells in the human colon and rectum. Cell Tissue Res 1978;192:227-40
   PubMed Web of Science ®Google Scholar
• Schonhoff SE, Giel-Moloney M, Leiter AB. Minireview: Development and differentiation of gut endocrine cells. Endocrinology 2004;145:2639-44
   PubMed Web of Science ®Google Scholar
• Sjolund K, Sanden G, Hakanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983;85:1120-30
   PubMed Web of Science ®Google Scholar
• Sandstrom O, El-Salhy M. Ageing and endocrine cells of human duodenum. Mech Ageing Dev 1999;108:39-48
   PubMed Web of Science ®Google Scholar
• Sandstrom O, el-Salhy M. Human rectal endocrine cells and aging. Mech Ageing Dev 1999;108:219-26
   PubMed Web of Science ®Google Scholar
• Mawe GM, Coates MD, Moses PL. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther 2006;23:1067-76
   PubMed Web of Science ®Google Scholar
• Wade PR, Chen J, Jaffe B, et al. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 1996;16:2352-64
   PubMed Web of Science ®Google Scholar
• Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007;132:397-414
   PubMed Web of Science ®Google Scholar
• Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 2013;20:14-21
   PubMed Web of Science ®Google Scholar
• Gershon MD. Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. Trans Am Clin Climatol Assoc 2012;123:268-80
   PubMedGoogle Scholar
• El-Salhy M, Mazzawi T, Gundersen D, et al. YY in gastrointestinal diseases and disorders (Review). Int J Mol Med 2013;31:275-82
   PubMed Web of Science ®Google Scholar
• Dubrasquet M, Bataille D, Gespach C. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats. Biosci Rep 1982;2:391-5
   PubMed Web of Science ®Google Scholar
• Schjoldager BT, Baldissera FG, Mortensen PE, et al. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur J Clin Invest 1988;18:499-503
   PubMed Web of Science ®Google Scholar
• Schjoldager B, Mortensen PE, Myhre J, et al. Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions. Dig Dis Sci 1989;34:1411-19
   PubMed Web of Science ®Google Scholar
• Dakin CL, Small CJ, Batterham RL, et al. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 2004;145:2687-95
   PubMed Web of Science ®Google Scholar
• Wynne K, Park AJ, Small CJ, et al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes 2005;54:2390-5
   PubMed Web of Science ®Google Scholar
• Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med 2012;367:1626-35
   PubMed Web of Science ®Google Scholar
• Jianu CS, Fossmark R, Syversen U, et al. A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia. Tumour Biol 2010;31:373-80
   PubMed Web of Science ®Google Scholar
• Seim I, El-Salhy M, Hausken T, et al. Ghrelin and the brain-gut axis as a pharmacological target for appetite control. Curr Pharm Des 2012;18:768-75
   PubMed Web of Science ®Google Scholar
• Lee CS, Kaestner KH. Clinical endocrinology and metabolism. Development of gut endocrine cells. Best Pract Res Clin Endocrinol Metab 2004;18:453-62
   PubMedGoogle Scholar
• Cardoso WV, Lu J. Regulation of early lung morphogenesis: questions, facts and controversies. Development (Cambridge, England) 2006;133:1611-24
   PubMed Web of Science ®Google Scholar
• Darlington GJ. Molecular mechanisms of liver development and differentiation. Curr Opin Cell Biol 1999;11:678-82
   PubMed Web of Science ®Google Scholar
• Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology (Baltimore, Md.) 2006;43:S45-53
   PubMedGoogle Scholar
• Rawlins EL, Hogan BL. Ciliated epithelial cell lifespan in the mouse trachea and lung. Am J Physiol Lung Cell Mol Physiol 2008;295:L231-4
   PubMed Web of Science ®Google Scholar
• Zaret KS. Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev Genet 2002;3:499-512
   PubMed Web of Science ®Google Scholar
• Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-7
   PubMed Web of Science ®Google Scholar
• Barker N, van de Wetering M, Clevers H. The intestinal stem cell. Genes Dev 2008;22:1856-64
   PubMed Web of Science ®Google Scholar
• Barker N, Clevers H. Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology 2007;133:1755-60
   PubMed Web of Science ®Google Scholar
• Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat 1974;141:537-61
   PubMedGoogle Scholar
• Fontaine J, Le Lievre C, Le Douarin NM. What is the developmental fate of the neural crest cells which migrate into the pancreas in the avian embryo? Gen Comp Endocrinol 1977;33:394-404
   PubMed Web of Science ®Google Scholar
• Le Douarin NM, Teillet MA. The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morphol 1973;30:31-48
   PubMedGoogle Scholar
• Rawdon BB, Andrew A. Origin and differentiation of gut endocrine cells. Histol Histopathol 1993;8:567-80
   PubMed Web of Science ®Google Scholar
• Hoffman J, Kuhnert F, Davis CR, Kuo CJ. Wnts as essential growth factors for the adult small intestine and colon. Cell cycle (Georgetown, Tex.) 2004;3:554-7
   PubMed Web of Science ®Google Scholar
• Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998;19:379-83
   PubMed Web of Science ®Google Scholar
• Montgomery RK, Breault DT. Small intestinal stem cell markers. J Anat 2008;213:52-8
   PubMed Web of Science ®Google Scholar
• Wendelbo I, Mazzawi T, El-Salhy M. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease. Mol Med Report 2013; In press
   Web of Science ®Google Scholar
• El-Salhy M, Wendelbo IH, Gundersen D. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome. Mol Med Rep 2013;7:1241-4
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Vaali K, Dizdar V, Hausken T. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Dig Dis Sci 2010;55:3508-13
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Mazzawi T, Gundersen D, Hausken T. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Report 2012;6:1223-5
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Lomholt-Beck B, Hausken T. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2010;45:1435-9
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Lillebo E, Reinemo A, Salmelid L. Ghrelin in patients with irritable bowel syndrome. Int J Mol Med 2009;23:703-7
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gundersen D, Hausken T. Endocrine cells in the gastric oxyntic mucosa of patients with irritable bowel syndrome. World J Gastrintest Endosc 2014;6:176-85
   PubMedGoogle Scholar
• El-Salhy M, Gundersen D, Ostgaard H, et al. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci 2012;57:873-8
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Chromogranin a cell density as a diagnostic marker for lymphocytic colitis. Dig Dis Sci 2012;57:3154-9
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gilja OH, Gundersen D, Hausken T. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. World J Gastrointest Endosc 2014;6(5):176-85
   PubMedGoogle Scholar
• El-Salhy M, Gilja OH, Hatlebakk JG, Hausken T. Stomach antral endocrine cells in patients with irritable bowel syndrome. Int J Mol Med 2014;34(4):967-74
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gilja OH, Hausken T. Chromogranin A cells in the stomach of patients with sporadic irritable bowel syndrome. Submitted to Histol Histopathol 2013;12(1):36-49
   Google Scholar
• Sjolund K, Ekman R, Wierup N. Covariation of plasma ghrelin and motilin in irritable bowel syndrome. Peptides 2010;31:1109-12
   PubMed Web of Science ®Google Scholar
• Wang SH, Dong L, Luo JY, et al. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol 2007;13:6041-7
   PubMed Web of Science ®Google Scholar
• Park JH, Rhee PL, Kim G, et al. Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2006;18:539-46
   PubMed Web of Science ®Google Scholar
• Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004;126:1657-64
   PubMed Web of Science ®Google Scholar
• Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004;53:1096-101
   PubMed Web of Science ®Google Scholar
• Dizdar V, Spiller R, Singh G, et al. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2010;31:883-91
   PubMed Web of Science ®Google Scholar
• Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003;125:1651-9
   PubMed Web of Science ®Google Scholar
• Lee KJ, Kim YB, Kim JH, et al. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008;23:1689-94
   PubMed Web of Science ®Google Scholar
• Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11
   PubMed Web of Science ®Google Scholar
• Kim HS, Lim JH, Park H, Lee SI. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study. Yonsei Med J 2010;51:45-51
   PubMed Web of Science ®Google Scholar
• Dunlop SP, Coleman NS, Blackshaw E, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:349-57
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Danielsson A, Stenling R, Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J Intern Med 1997;242:413-19
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Wendelbo I, Gundersen D. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease. Mol Med Rep 2013;8:451-5
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Hausken T. The reduction in duodenal endocrine cells in IBS is associated with stem cell abnormality. World J Gastroenterol 2015; In press
   PubMedGoogle Scholar
• Camilleri M. Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol 2014;592:2967-80
   PubMed Web of Science ®Google Scholar
• Ohman L, Tornblom H, Simren M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev. Gastroenterology & hepatology 2015;12:36-49
   PubMed Web of Science ®Google Scholar
• Camilleri M. Intestinal Secretory Mechanisms in Irritable Bowel Syndrome-Diarrhea. Clin Gastroenterol Hepatol 2014;13(6):1051-7
   PubMed Web of Science ®Google Scholar
• Taupenot L, Harper KL, O’Connor DT. The chromogranin-secretogranin family. N Engl J Med 2003;348:1134-49
   PubMed Web of Science ®Google Scholar
• Wiedenmann B, Huttner WB. Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;58:95-121
   PubMedGoogle Scholar
• Deftos LJ. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev 1991;12:181-7
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gilja OH, Gundersen D, et al. Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome. Gastroenterol Res Pract 2014;2014:462856
   PubMed Web of Science ®Google Scholar
• El-Salhy M. The nature and implication of intestinal endocrine cell changes in coeliac disease. Histol Histopathol 1998;13:1069-75
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept 2014;188:60-5
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome. Regul Pept 2015;67:12-19
   Google Scholar
• Sjolund K, Ekman R. Increased plasma levels of peptide YY in coeliac disease. Scand J Gastroenterol 1988;23:297-300
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Mahdavi J, Norrgard O. Colonic endocrine cells in patients with carcinoma of the colon. Eur J Gastroenterol Hepatol 1998;10:517-22
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World J Gastroenterol 2012;18:6070-5
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Norrgård O, Franzen L, Forsgren S. Colonic endocrine cells in rectal carcinoma, with particular regard to preoperative irradiation. GI Cancer 1997;2:285-92
   Web of Science ®Google Scholar
• Sood R, Gracie DJ, Law GR, Ford AC. Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers. Aliment Pharmacol Ther 2015. [Epub ahead of print]
   PubMedGoogle Scholar
• Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterology & hepatology. 2010;7:163-73
   Google Scholar
• Barbara G, De Giorgio R, Stanghellini V, et al. A role for inflammation in irritable bowel syndrome? Gut 2002;51(Suppl 1):i41-4
   PubMed Web of Science ®Google Scholar
• Schmulson M, Chey WD. Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all? Am J Gastroenterol 2012;107:273-5
   PubMed Web of Science ®Google Scholar
• Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6
   PubMed Web of Science ®Google Scholar
• Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003;52:523-6
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome. Mol Med Rep 2013;7:1081-5
   PubMed Web of Science ®Google Scholar
• Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-83
   PubMed Web of Science ®Google Scholar
• Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009;104:392-400
   PubMed Web of Science ®Google Scholar
• Akbar A, Yiangou Y, Facer P, et al. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 2010;59:767-74
   PubMed Web of Science ®Google Scholar
• Cenac N, Andrews CN, Holzhausen M, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007;117:636-47
   PubMed Web of Science ®Google Scholar
• Klooker TK, Braak B, Koopman KE, et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010;59(9):1213-21
   PubMed Web of Science ®Google Scholar
• Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007;132:913-20
   PubMed Web of Science ®Google Scholar
• Macsharry J, O’Mahony L, Fanning A, et al. Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol 2008;43:1467-76
   PubMed Web of Science ®Google Scholar
• Piche T, Barbara G, Aubert P, et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009;58:196-201
   PubMed Web of Science ®Google Scholar
• Chang L, Adeyemo M, Karagiannides I, et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol 2012;107:262-72
   PubMed Web of Science ®Google Scholar
• Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007;42(Suppl 17):41-7
   PubMedGoogle Scholar
• Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis 2009;41:844-9
   PubMedGoogle Scholar
• Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol 2006;22:13-17
   PubMed Web of Science ®Google Scholar
• Pimentel M, Morales W, Rezaie A, et al. Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects. PLoS One 2015;10:e0126438
   PubMed Web of Science ®Google Scholar
• Caviglia GP, Pantaleoni S, Touscoz GA, et al. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders. Scand J Gastroenterol 2014;49:1419-24
   PubMed Web of Science ®Google Scholar
• David LE, Surdea-Blaga T, Dumitrascu DL. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study. Sao Paulo Medical J 2014;19; Epub ahead of print
   Google Scholar
• Burri E, Beglinger C. Faecal calprotectin in the diagnosis of inflammatory bowel disease. Biochemia medica 2011;21:245-53
   PubMed Web of Science ®Google Scholar
• Shastri Y, Povse N, Stein J. A prospective comparative study for new rapid bedside fecal calprotectin test with an established ELISA to assess intestinal inflammation. Clin Lab 2009;55:53-5
   PubMed Web of Science ®Google Scholar
• Kalantari H, Taheri A, Yaran M. Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome. Advanced biomedical research 2015;4:85
   PubMedGoogle Scholar
• Menees SB, Powell C, Kurlander J, et al. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol 2015;110:444-54
   PubMed Web of Science ®Google Scholar
• Chang MH, Chou JW, Chen SM, et al. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome. Mol Med Rep 2014;10:522-6
   Web of Science ®Google Scholar
• Dabritz J, Musci J, Foell D. Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome. World J Gastroenterol 2014;20:363-75
   PubMed Web of Science ®Google Scholar
• Locke GRIII, Zinsmeister AR, Talley NJ, et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000;75:907-12
   PubMed Web of Science ®Google Scholar
• Kalantar JS, Locke GRIII, Zinsmeister AR, et al. Familial aggregation of irritable bowel syndrome: a prospective study. Gut 2003;52:1703-7
   PubMed Web of Science ®Google Scholar
• Saito YA, Zimmerman JM, Harmsen WS, et al. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil 2008;20:790-7
   PubMed Web of Science ®Google Scholar
• Saito YA, Petersen GM, Larson JJ, et al. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol 2010;105:833-41
   PubMed Web of Science ®Google Scholar
• Waehrens R, Ohlsson H, Sundquist J, et al. Risk of irritable bowel syndrome in first-degree, second-degree and thirddegree relatives of affected individuals: a nationwide family study in Sweden. Gut 2015;64(2):215-21
   PubMed Web of Science ®Google Scholar
• Morris-Yates A, Talley NJ, Boyce PM, et al. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998;93:1311-17
   PubMed Web of Science ®Google Scholar
• Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001;121:799-804
   PubMed Web of Science ®Google Scholar
• Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014;109(Suppl 1):S2-26
   PubMed Web of Science ®Google Scholar
• Bengtson MB, Ronning T, Vatn MH, Harris JR. Irritable bowel syndrome in twins: genes and environment. Gut 2006;55:1754-9
   PubMed Web of Science ®Google Scholar
• Mohammed I, Cherkas LF, Riley SA, et al. Genetic influences in irritable bowel syndrome: a twin study. Am J Gastroenterol 2005;100:1340-4
   PubMed Web of Science ®Google Scholar
• Lembo A, Zaman M, Jones M, Talley NJ. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther 2007;25:1343-50
   PubMed Web of Science ®Google Scholar
• Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 2009;16:53-9
   PubMed Web of Science ®Google Scholar
• Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012;303:G775-85
   PubMed Web of Science ®Google Scholar
• Saito YA. The role of genetics in IBS. Gastroenterol Clin North Am 2011;40:45-67
   PubMed Web of Science ®Google Scholar
• Saito YA, Mitra N, Mayer EA. Genetic approaches to functional gastrointestinal disorders. Gastroenterology 2010;138:1276-85
   PubMed Web of Science ®Google Scholar
• D’Amato M. Genes and functional GI disorders: from casual to causal relationship. Neurogastroenterol Motil 2013;25:638-49
   PubMed Web of Science ®Google Scholar
• Camilleri M. Genetics of human gastrointestinal sensation. Neurogastroenterol Motil 2013;25:458-66
   PubMed Web of Science ®Google Scholar
• Van Kerkhoven LA, Laheij RJ, Jansen JB. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther 2007;26:979-86
   PubMed Web of Science ®Google Scholar
• Jarrett ME, Kohen R, Cain KC, et al. Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs 2007;9:161-9
   PubMed Web of Science ®Google Scholar
• Kohen R, Jarrett ME, Cain KC, et al. The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome. Dig Dis Sci 2009;54:2663-70
   PubMed Web of Science ®Google Scholar
• Yuan J, Kang C, Wang M, et al. Association study of serotonin transporter SLC6A4 gene with Chinese Han irritable bowel syndrome. PLoS ONE 2014;9:e84414
   PubMedGoogle Scholar
• Zucchelli M, Camilleri M, Andreasson AN, et al. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut 2011;60:1671-7
   PubMed Web of Science ®Google Scholar
• Wouters MM, Lambrechts D, Knapp M, et al. Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome. Gut 2014;63:1103-11
   PubMed Web of Science ®Google Scholar
• Swan C, Duroudier NP, Campbell E, et al. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFalpha. Gut 2013;62:985-94
   PubMed Web of Science ®Google Scholar
• Ek WE, Reznichenko A, Ripke S, et al. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts. Gut 2014; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Napolioni V. The relevance of checking population allele frequencies and Hardy-Weinberg Equilibrium in genetic association studies: The case of SLC6A4 5-HTTLPR polymorphism in a Chinese Han Irritable Bowel Syndrome association study. Immunol Lett 2014;162:276-8
   PubMed Web of Science ®Google Scholar
• Camilleri M, Klee EW, Shin A, et al. Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit. Am J Physiol Gastrointest Liver Physiol 2014;306:G13-26
   PubMed Web of Science ®Google Scholar
• Camilleri M, Kolar GJ, Vazquez-Roque MI, et al. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits. Am J Physiol Gastrointest Liver Physiol 2013;304:G553-60
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, Carlson PJ, et al. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig Dis Sci 2012;57:1222-6
   PubMed Web of Science ®Google Scholar
• Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol 2014;20:8886-97
   PubMed Web of Science ®Google Scholar
• Lee KJ, Tack J. Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:493-8
   PubMed Web of Science ®Google Scholar
• Simren M. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup? Gut 2014;63:1685-6
   PubMed Web of Science ®Google Scholar
• Dore J, Simren M, Buttle L, Guarner F. Hot topics in gut microbiota. United Eur Gastroenterol J 2013;1:311-18
   Google Scholar
• Ohman L, Simren M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep 2013;15:323
   PubMedGoogle Scholar
• Carroll IM, Ringel-Kulka T, Keku TO, et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011;301:G799-807
   PubMed Web of Science ®Google Scholar
• Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005;100:373-82
   PubMed Web of Science ®Google Scholar
• Matto J, Maunuksela L, Kajander K, et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005;43:213-22
   PubMed Web of Science ®Google Scholar
• Maukonen J, Satokari R, Matto J, et al. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006;55:625-33
   PubMed Web of Science ®Google Scholar
• Malinen E, Krogius-Kurikka L, Lyra A, et al. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol 2010;16:4532-40
   PubMed Web of Science ®Google Scholar
• Rajilic-Stojanovic M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011;141:1792-801
   PubMed Web of Science ®Google Scholar
• Jeffery IB, O’Toole PW, Ohman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012;61:997-1006
   PubMed Web of Science ®Google Scholar
• Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012;24:521-30
   PubMed Web of Science ®Google Scholar
• Carroll IM, Ringel-Kulka T, Siddle JP, et al. Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One 2012;7:e46953
   PubMed Web of Science ®Google Scholar
• Carroll IM, Chang YH, Park J, et al. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog 2010;2:19
   PubMed Web of Science ®Google Scholar
• Codling C, O’Mahony L, Shanahan F, et al. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2010;55:392-7
   PubMed Web of Science ®Google Scholar
• Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007;133:24-33
   PubMed Web of Science ®Google Scholar
• Kerckhoffs AP, ter Linde JJ, Akkermans LM, Samsom M. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol 2012;302:G1053-60
   PubMed Web of Science ®Google Scholar
• Krogius-Kurikka L, Lyra A, Malinen E, et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 2009;9:95
   PubMed Web of Science ®Google Scholar
• Noor SO, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol 2010;10:134
   PubMed Web of Science ®Google Scholar
• Le Gall G, Noor SO, Ridgway K, et al. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res 2011;10:4208-18
   PubMed Web of Science ®Google Scholar
• Saulnier DM, Riehle K, Mistretta TA, et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011;141:1782-91
   PubMed Web of Science ®Google Scholar
• Tana C, Umesaki Y, Imaoka A, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:512-19
   PubMed Web of Science ®Google Scholar
• Jalanka-Tuovinen J, Salojarvi J, Salonen A, et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 2014;63:1737-45
   PubMed Web of Science ®Google Scholar
• Rigsbee L, Agans R, Shankar V, et al. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2012;107:1740-51
   PubMed Web of Science ®Google Scholar
• Ponnusamy K, Choi JN, Kim J, et al. Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol 2011;60:817-27
   PubMed Web of Science ®Google Scholar
• Carroll IM, Ringel-Kulka T, Ferrier L, et al. Fecal protease activity is associated with compositional alterations in the intestinal microbiota. PLoS One 2013;8:e78017
   PubMedGoogle Scholar
• Durban A, Abellan JJ, Jimenez-Hernandez N, et al. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome. FEMS Microbiol Ecol 2013;86(3):581-9
   PubMed Web of Science ®Google Scholar
• Balsari A, Ceccarelli A, Dubini F, et al. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982;5:185-94
   PubMed Web of Science ®Google Scholar
• Durban A, Abellan JJ, Jimenez-Hernandez N, et al. Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome. Environ Microbiol Rep 2012;4:242-7
   PubMed Web of Science ®Google Scholar
• Rinttila T, Lyra A, Krogius-Kurikka L, Palva A. Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog 2011;3:6
   PubMedGoogle Scholar
• Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004;10:1802-5
   PubMed Web of Science ®Google Scholar
• Furnari M, Savarino E, Bruzzone L, et al. Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin Liver Dis 2012;21:157-63
   PubMed Web of Science ®Google Scholar
• Carbonero F, Benefiel AC, Gaskins HR. Contributions of the microbial hydrogen economy to colonic homeostasis. Nat Rev Gastroenterol Hepatol 2012;9:504-18
   PubMed Web of Science ®Google Scholar
• Kim G, Deepinder F, Morales W, et al. Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Dig Dis Sci 2012;57:3213-18
   PubMed Web of Science ®Google Scholar
• Lee OY. Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil 2010;16:120-30
   PubMedGoogle Scholar
• Gunnarsson J, Simren M. Peripheral factors in the pathophysiology of irritable bowel syndrome. Dig Liver Dis 2009;41:788-93
   PubMedGoogle Scholar
• Whorwell PJ, Clouter C, Smith CL. Oesophageal motility in the irritable bowel syndrome. Br Med J (Clin Res Ed) 1981;282:1101-2
   PubMed Web of Science ®Google Scholar
• Clouse RE, Eckert TC. Gastrointestinal symptoms of patients with esophageal contraction abnormalities. Dig Dis Sci 1986;31:236-40
   PubMed Web of Science ®Google Scholar
• Soffer EE, Scalabrini P, Pope CEII, Wingate DL. Effect of stress on oesophageal motor function in normal subjects and in patients with the irritable bowel syndrome. Gut 1988;29:1591-4
   PubMed Web of Science ®Google Scholar
• Lind CD. Motility disorders in the irritable bowel syndrome. Gastroenterol Clin North Am 1991;20:279-95
   PubMed Web of Science ®Google Scholar
• van Wijk HJ, Smout AJ, Akkermans LM, et al. Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome. Scand J Gastroenterol 1992;27:99-102
   PubMed Web of Science ®Google Scholar
• Charles F, Phillips SF, Camilleri M, Thomforde GM. Rapid gastric emptying in patients with functional diarrhea. Mayo Clin Proc 1997;72:323-8
   PubMed Web of Science ®Google Scholar
• Caballero-Plasencia AM, Valenzuela-Barranco M, Herrerias-Gutierrez JM, Esteban-Carretero JM. Altered gastric emptying in patients with irritable bowel syndrome. Eur J Nucl Med 1999;26:404-9
   PubMedGoogle Scholar
• Portincasa P, Moschetta A, Baldassarre G, et al. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol 2003;9:2293-9
   PubMed Web of Science ®Google Scholar
• Stanghellini V, Tosetti C, Barbara G, et al. Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol 2002;97:2738-43
   PubMed Web of Science ®Google Scholar
• Leahy A, Besherdas K, Clayman C, et al. Abnormalities of the electrogastrogram in functional gastrointestinal disorders. Am J Gastroenterol 1999;94:1023-8
   PubMed Web of Science ®Google Scholar
• Evans PR, Bak YT, Shuter B, et al. Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Dig Dis Sci 1997;42:2087-93
   PubMed Web of Science ®Google Scholar
• Camilleri M, McKinzie S, Busciglio I, et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008;6:772-81
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Gjorup T, Christensen FN. Gastric emptying rate and small bowel transit time in patients with irritable bowel syndrome determined with 99mTc-labeled pellets and scintigraphy. Dig Dis Sci 1986;31:1287-91
   PubMed Web of Science ®Google Scholar
• Narducci F, Bassotti G, Granata MT, et al. Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci 1986;31:241-6
   PubMed Web of Science ®Google Scholar
• Acharya U, Waite N, Howlett P, et al. Failure to demonstrate altered gastric emptying in irritable bowel syndrome. Dig Dis Sci 1983;28:889-92
   PubMed Web of Science ®Google Scholar
• Dinning PG, Arkwright JW, Gregersen H, et al. Technical advances in monitoring human motility patterns. Neurogastroenterol Motil 2010;22:366-80
   PubMed Web of Science ®Google Scholar
• Bampton PA, Dinning PG. High resolution colonic manometry--what have we learnt?--A review of the literature. 2012. Curr Gastroenterol Rep 2013;15:328
   PubMedGoogle Scholar
• Penning C, Gielkens HA, Hemelaar M, et al. Reproducibility of antroduodenal motility during prolonged ambulatory recording. Neurogastroenterol Motil 2001;13:133-41
   PubMed Web of Science ®Google Scholar
• Hasler WL, Saad RJ, Rao SS, et al. Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS. Am J Physiol Gastrointest Liver Physiol 2009;297:G1107-14
   PubMed Web of Science ®Google Scholar
• Metcalf AM, Phillips SF, Zinsmeister AR, et al. Simplified assessment of segmental colonic transit. Gastroenterology 1987;92:40-7
   PubMed Web of Science ®Google Scholar
• Camilleri M, Bharucha AE, di Lorenzo C, et al. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil 2008;20:1269-82
   PubMed Web of Science ®Google Scholar
• Posserud I, Syrous A, Lindstrom L, et al. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology 2007;133:1113-23
   PubMed Web of Science ®Google Scholar
• Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973;14:125-32
   PubMed Web of Science ®Google Scholar
• Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 1998;115:1263-71
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Holtkotter B, Enck P, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990;98:1187-92
   PubMed Web of Science ®Google Scholar
• Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002;122:1771-7
   PubMed Web of Science ®Google Scholar
• Bradette M, Delvaux M, Staumont G, et al. Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects. Dig Dis Sci 1994;39:449-57
   PubMed Web of Science ®Google Scholar
• Costantini M, Sturniolo GC, Zaninotto G, et al. Altered esophageal pain threshold in irritable bowel syndrome. Dig Dis Sci 1993;38:206-12
   PubMed Web of Science ®Google Scholar
• Trimble KC, Farouk R, Pryde A, et al. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 1995;40:1607-13
   PubMed Web of Science ®Google Scholar
• Zighelboim J, Talley NJ, Phillips SF, et al. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci 1995;40:819-27
   PubMed Web of Science ®Google Scholar
• Accarino AM, Azpiroz F, Malagelada JR. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology 1995;108:636-43
   PubMed Web of Science ®Google Scholar
• Kanazawa M, Hongo M, Fukudo S. Visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol 2011;26(Suppl 3):119-21
   PubMedGoogle Scholar
• Kanazawa M, Palsson OS, Thiwan SI, et al. Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol 2008;103:2550-61
   PubMed Web of Science ®Google Scholar
• van der Veek PP, Van Rood YR, Masclee AA. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome. Clin Gastroenterol Hepatol 2008;6:321-8
   PubMed Web of Science ®Google Scholar
• Kuiken SD, Lindeboom R, Tytgat GN, Boeckxstaens GE. Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:157-64
   PubMed Web of Science ®Google Scholar
• Lee KJ, Kim JH, Cho SW. Relationship of underlying abnormalities in rectal sensitivity and compliance to distension with symptoms in irritable bowel syndrome. Digestion 2006;73:133-41
   PubMed Web of Science ®Google Scholar
• Sabate JM, Veyrac M, Mion F, et al. Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2008;28:484-90
   PubMed Web of Science ®Google Scholar
• Camilleri M, Shin A, Busciglio I, et al. Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil 2014;26:1677-85
   PubMed Web of Science ®Google Scholar
• Lembo AJ, Neri B, Tolley J, et al. Use of serum biomarkers in a diagnostic test for irritable bowel syndrome. Aliment Pharmacol Ther 2009;29:834-42
   PubMed Web of Science ®Google Scholar
• Jones MP, Chey WD, Singh S, et al. A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther 2014;39:426-37
   PubMed Web of Science ®Google Scholar